CGH
ROIV icon

Crossmark Global Holdings’s Roivant Sciences ROIV Stock Holding History

Crossmark Global Holdings’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$906K Hold
25,607
– – 0.01% 659
2026
Q1 		$709K Hold
25,607
– – 0.01% 721
2025
Q4 		$556K Buy
25,607
+2,842
+12% +$56.1K 0.01% 796
2025
Q3 		$344K Buy
22,765
+1,572
+7% +$19.5K 0.01% 1041
2025
Q2 		$239K Buy
21,193
+309
+1% +$3.35K ﹤0.01% 1197
2025
Q1 		$211K Buy
20,884
+336
+2% +$3.63K ﹤0.01% 1248
2024
Q4 		$243K Sell
20,548
-46
-0.2% -$544 ﹤0.01% 1135
2024
Q3 		$238K Hold
20,594
– – ﹤0.01% 1176
2024
Q2 		$218K Buy
+20,594
New +$226K ﹤0.01% 1202

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Crossmark Global Holdings's ROIV Position: Q2 2026 in Review

Crossmark Global Holdings held its Roivant Sciences (ROIV) position steady in Q2 2026 at 25,607 shares worth $906K. The position accounts for 0.01% of the portfolio, ranked #659.

Crossmark Global Holdings first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Crossmark Global Holdings held 25,607 shares of Roivant Sciences worth $906K as of Q2 2026.
  • Crossmark Global Holdings left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #659 holding.
  • Crossmark Global Holdings first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.